Source study found

Story checked

New method detects lung antibodies through non-invasive exhaled breath (opens in a new tab)

news-medical.net · 2026-11-04

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

3 supported
2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

New method detects lung antibodies through non-invasive exhaled breath

news-medical.net · 2026-11-04

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Three of five claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

3 supported
2 not covered

Open claim evidence

The source study

Non-invasive quantification of lower airway antigen-specific antibodies using exhaled breath particles - an observational proof-of-concept study.

EBioMedicine · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5Not coveredFor the first time, researchers successfully measured antibodies against specific respiratory viruses in exhaled air in a new study involving the Karolinska Institutet and published in eBioMedicine.View evidenceHide evidence

As statedfor the first time

Why this verdict

The abstract-level profile supports that PExA was used to quantify virus-antigen-specific IgA and IgG in exhaled/distal-airway samples. However, the story’s prominent 'for the first time' framing, Karolinska involvement, and eBioMedicine publication details are not established in the supplied abstract profile, so those parts are not verifiable at this depth.

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

Claim 2 of 5Not coveredThe researchers said the method may help study how immunity differs between the upper and lower airways and could be useful for tracking responses after infections or vaccinations and evaluating preventive treatments, but emphasized that this was an initial methodological study needing further validation in larger studies.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the method’s potential relevance for comparing airway compartments and supports the caveat that this is a small proof-of-concept study needing broader validation. However, the more specific claimed applications—tracking responses after infections or vaccinations and evaluating preventive treatments—are not fully established in the supplied abstract profile, so the full researcher-said application claim is not verifiable at this depth.

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

Study evidence

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001

Claim 3 of 5SupportedThe method uses PExA, a non-invasive device that collects tiny exhaled particles originating from the respiratory tract lining fluid of the small airways.View evidenceHide evidence

Why this verdict

The paper profile states that PExA is a non-invasive method capturing aerosolised respiratory tract lining fluid from the distal airways/exhaled breath particles, matching the story’s description of a non-invasive device collecting tiny exhaled particles from small-airway lining fluid.

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

Claim 4 of 5SupportedIn 28 participants, including 18 who had recently experienced a respiratory tract infection, the researchers analysed paired blood, nasal secretion, and exhaled-breath samples.View evidenceHide evidence

As stated28 participants; 18 with recent respiratory tract infection

Why this verdict

The profile reports paired PExA, serum, and nasal secretion samples from 28 healthcare workers, 18 with RT-qPCR-confirmed respiratory viral infection. The story’s 'blood, nasal secretion, and exhaled-breath samples' wording corresponds to serum, nasal secretions, and PExA samples.

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

Study evidence

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001

Claim 5 of 5SupportedThe exhaled breath samples contained IgA and IgG antibodies directed against SARS-CoV-2, influenza virus, and RSV, and lower-airway IgG largely mirrored blood levels while IgA showed a different pattern consistent with local mucosal responses.View evidenceHide evidence

Why this verdict

The profile supports quantification of antigen-specific IgA and IgG in PExA samples for SARS-CoV-2 spike, influenza H1, and RSV pre-F targets. It also reports strong PExA-serum IgG correlations and more modest IgA correlations/different IgA:IgG ratios, consistent with the story’s hedged interpretation that IgG largely mirrored blood while IgA showed a different mucosal pattern. The paper profile cautions that local production/source is inferential rather than proven.

Study evidence

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.

Study evidence

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

The paper includes analytical performance evidence, including low variability coefficients of variation for selected PExA IgA measurements.
The story says the method successfully measured antibodies but does not mention the reported repeatability/variability data that support technical feasibility.
From Non-invasive PExA sampling; paired biospecimen comparison; analytical precision assessment
The abstract does not specify the immunoassay platform or detailed lab protocols, limiting replication and assessment of analytical validity beyond reported CVs.
The story mentions the need for further validation but does not mention the missing assay/platform and protocol detail noted in the paper profile.
From Non-invasive PExA sampling; paired biospecimen comparison; analytical precision assessment; Observational paired-sample

4 things the story did carry across

The paper’s primary contribution is feasibility of using non-invasive PExA to quantify antigen-specific IgA and IgG in distal-airway respiratory tract lining fluid.
The study used paired PExA, serum, and nasal secretion samples from 28 participants, including 18 with RT-qPCR-confirmed respiratory viral infection.
Cross-compartment findings showed strong PExA-serum IgG correlations, more modest IgA correlations, and different IgA/IgG ratios between nasal secretions and PExA.
A key limitation is the small proof-of-concept sample, limiting precision and generalizability and requiring larger validation studies.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoDemonstrate feasibility and technical performance (repeatability/variability) of using Particles in Exhaled Air (PExA) to non-invasively quantify distal-airway (RTLF) antigen-specific IgA and IgG.Non-invasive PExA sampling; paired biospecimen comparison; analytical precision assessmentExpand

In plain English

Proof-of-concept observational study showing that non-invasive PExA sampling of exhaled breath particles (distal-airway RTLF) can be used to quantify antigen-specific IgA and IgG with low measured variability; paired serum and nasal samples in 28 healthcare workers (18 with RT-qPCR-confirmed infection) were used to assess assay performance and compartment correlations.

Key findings

PExA-collected distal-airway RTLF enabled quantification of antigen-specific antibodies with low measured variability.Median CVs in PExA: spike-IgA 3.7%; H1-IgA 7.2%; RSV pre-F-IgA 5.3%.
Measurements in PExA correlated strongly with serum for IgG.Spearman's rho > 0.85 (p < 0.0001) between PExA and serum IgG.

What this piece can’t prove

Small proof-of-concept sample (28 participants) limits precision of estimates and generalizability.
Abstract does not specify the immunoassay platform, limits replication and assessment of analytical validity beyond reported CVs.

1 further detail could not be confirmed from the summary.

2human in vivoCharacterize biological relationships between lower-airway (PExA) antibodies and paired systemic/upper-airway compartments (serum and nasal secretions), including correlations and isotype-ratio differences.Observational paired-sample cross-sectional analysis (human, in vivo)Expand

In plain English

Within 28 participants sampled pairwise (PExA lower-airway RTLF, serum, nasal secretions), antigen-specific IgG measured in PExA strongly correlated with serum IgG (Spearman's rho >0.85, p<0.0001), whereas antigen-specific IgA correlations with serum were more modest. Both IgG and IgA in PExA correlated with nasal secretions. The IgA/IgG ratio was substantially higher in nasal secretions than in PExA (median 5.0 vs 0.6, p<0.0001), consistent with different isotype distributions between upper and lower airway compartments.

Key findings

Antigen-specific IgG measured in PExA strongly correlated with serum IgG within participants.Spearman's rho >0.85, p < 0.0001
Antigen-specific IgA correlations between PExA and serum were more modest than for IgG.

What this piece can’t prove

Relatively small sample size (n=28) limits precision and generalisability.
Correlational data do not prove the origin of antibodies (systemic transfer vs local production); interpretation of source is inferential.

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer